Charles J. Casamento has not been actively trading shares of Relmada Therapeutics in the last ninety days. Most recently, on Monday, September 9th, Charles J. Casamento bought 13,000 shares of Relmada Therapeutics stock. The stock was acquired at an average cost of $2.56 per share, with a total value of $33,280.00. Following the completion of the transaction, the director now directly owns 13,000 shares of the company's stock, valued at $33,280. Learn More on Charles J. Casamento's trading history.